CA2440008A1 - Us0204917genes de rats en rapport avec la toxicologie, et leurs utilisations - Google Patents

Us0204917genes de rats en rapport avec la toxicologie, et leurs utilisations Download PDF

Info

Publication number
CA2440008A1
CA2440008A1 CA002440008A CA2440008A CA2440008A1 CA 2440008 A1 CA2440008 A1 CA 2440008A1 CA 002440008 A CA002440008 A CA 002440008A CA 2440008 A CA2440008 A CA 2440008A CA 2440008 A1 CA2440008 A1 CA 2440008A1
Authority
CA
Canada
Prior art keywords
genes
gene
gene sequences
responsive
partial gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002440008A
Other languages
English (en)
Inventor
Georgia Farris
Samuel H. Hicken
Spencer B. Farr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phase-1 Molecular Toxicology Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2440008A1 publication Critical patent/CA2440008A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

L'invention porte sur un ensemble de gènes de rats en rapport avec la toxicologie et s'avérant utiles pour déterminer les réponses toxicologiques.
CA002440008A 2001-01-29 2002-01-29 Us0204917genes de rats en rapport avec la toxicologie, et leurs utilisations Abandoned CA2440008A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26493301P 2001-01-29 2001-01-29
US60/264,933 2001-01-29
US30816101P 2001-07-26 2001-07-26
US60/308,161 2001-07-26
PCT/US2002/002935 WO2002066682A2 (fr) 2001-01-29 2002-01-29 Us0204917genes de rats en rapport avec la toxicologie, et leurs utilisations

Publications (1)

Publication Number Publication Date
CA2440008A1 true CA2440008A1 (fr) 2002-08-29

Family

ID=26950838

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002440008A Abandoned CA2440008A1 (fr) 2001-01-29 2002-01-29 Us0204917genes de rats en rapport avec la toxicologie, et leurs utilisations

Country Status (5)

Country Link
EP (1) EP1368499A2 (fr)
JP (1) JP2004535776A (fr)
AU (1) AU2002258387A1 (fr)
CA (1) CA2440008A1 (fr)
WO (1) WO2002066682A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
US8222005B2 (en) * 2003-09-17 2012-07-17 Agency For Science, Technology And Research Method for gene identification signature (GIS) analysis
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
WO2008069342A1 (fr) * 2006-12-05 2008-06-12 Incorporated Administrative Agency National Agriculture And Food Research Organization Sonde de détermination de caractère allergène ou anti-allergène
KR101794638B1 (ko) 2008-06-10 2017-12-04 상가모 테라퓨틱스, 인코포레이티드 Ｂａｘ- 및 ｂａｋ-결함 세포주들의 제조 방법 및 조성물
WO2013167153A1 (fr) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Anticorps utiles dans le diagnostic du cancer
CN112516125B (zh) * 2020-12-23 2024-03-15 西北农林科技大学 酪氨酸在制备防治葛根素注射剂诱发的血管内溶血的药物上的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012760A2 (fr) * 1998-08-28 2000-03-09 Incyte Pharmaceuticals, Inc. Marqueurs de reaction toxicologique

Also Published As

Publication number Publication date
AU2002258387A1 (en) 2002-09-04
WO2002066682A3 (fr) 2002-12-19
EP1368499A2 (fr) 2003-12-10
JP2004535776A (ja) 2004-12-02
WO2002066682A2 (fr) 2002-08-29

Similar Documents

Publication Publication Date Title
JP6448149B2 (ja) 肝線維症に関連する遺伝的多型、その検出方法および使用
WO2001032928A9 (fr) Methodes permettant de determiner une hypersensibilite a un agent
JP5649263B2 (ja) 心臓血管障害および薬物応答に関連した遺伝子多型、それらの検出方法および用途
WO2001036684A2 (fr) Marqueurs de reaction toxicologique
US20040067500A1 (en) Compositions and methods relating to the peroxisomal proliferator activated receptor-alpha mediated pathway
JP2001524311A (ja) 遺伝子転写における環境刺激性物質の毒性／病理学上の影響を同定する方法
CA2440008A1 (fr) Us0204917genes de rats en rapport avec la toxicologie, et leurs utilisations
Wei et al. Gene expression profiles in liver of zebrafish treated with microcystin-LR
EP1581095A2 (fr) Methodes therapeutiques de reduction du depot de graisse et traitement des etats associes
US7776313B2 (en) Methods of diagnosing and treating rheumatoid arthritis and osteoarthritis
EP1427850A2 (fr) Genes et jeux ordonnes d'echantillons humains pertinents sur le plan toxicologique
WO2000012760A2 (fr) Marqueurs de reaction toxicologique
JP2007528707A (ja) 統合失調症の診断および治療のための標的としてのｅｇｒ遺伝子
JP2006526986A (ja) 炎症性大腸炎の診断方法
EP1693452B1 (fr) Procede pour estimer la toxicite de medicaments
US7091033B2 (en) Array of toxicologically relevant canine genes and uses thereof
US20030175797A1 (en) Association of protein kinase C zeta polymorphisms with diabetes
US6762021B2 (en) Method for diagnosis of crohn's disease
US20030054418A1 (en) Gene and sequence variation associated with cancer
US20030064372A1 (en) Gene and sequence variation associated with lipid disorder
JP4121764B2 (ja) 血栓形成傾向素因の検査方法
JP4819791B2 (ja) リン脂質症の判定方法
JP2006115749A (ja) Ｎｒ２ｂ遺伝子の発現レベルに基づき化学物質が有する発達神経毒性を検出する方法
JPWO2003016570A1 (ja) ＩＬ−１β遺伝子の多型を利用した肝細胞癌の検査方法
JP2006115748A (ja) Ｎｒ２ａ遺伝子の発現レベルに基づき化学物質が有する発達神経毒性を検出する方法

Legal Events

Date Code Title Description
FZDE Dead